Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indo Boga Sukses Tbk. (IBOS) vs Indofarma Tbk. (INAF) Price & Performance

Indo Boga Sukses Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

Indo Boga Sukses Tbk. vs Indofarma Tbk. — how do they compare? Indo Boga Sukses Tbk. trades at Rp97 (market cap 782.38B, 3.95M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Indo Boga Sukses Tbk. is far larger — about 2× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

IBOSINAF
Market Cap
782.38B390.51B
Volume
3.95M
Lot
39.48K
Turnover
375.36M
Average Price
95.07
Value
375.36M
Indicative Equilibrium Price
97
Indicative Equilibrium Volume
238

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IBOS
View details
INAF
View details

About Indo Boga Sukses Tbk.

PT Indo Boga Sukses Tbk (”the Company”) was established based on notarial deed No. 6 dated January 16, 2019 of Tabitha Sri Jeany, S.H, MKn., notary in Yogyakarta.

Read more on IBOS

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF